Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
$2.79
-$0.12(-2.72%)
At close: 4:00 PM EST
$2.79
-$0.12(-2.72%)
Day’s Range― - ―
52-Week Range$2.66 - $5.81
Previous CloseN/A
Volume261.88K
Average Volume (3M)4.40M
Market Cap
$913.07M
Enterprise Value$1.74B
Total Cash (Recent Filing)$273.53M
Total Debt (Recent Filing)$545.13M
Price to Earnings (P/E)31.3
Beta0.89
Next Earnings
Feb 26, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding105,468,834
10 Day Avg. Volume3,063,398
30 Day Avg. Volume4,403,860
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)2.48
Price to Sales (P/S)2.26
P/FCF Ratio15.80
Enterprise Value/Market Cap1.91
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit2.39
Enterprise Value/Ebitda9.89
Forecast
1Y Price Target
$4.97Price Target Upside78.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)0.36
Revenue Forecast (FY)$795.24M
Bulls Say, Bears Say
Bulls Say
New Revenue StreamsThe subscription offering creates new revenue streams that can help stabilize revenue growth over time.
Partnership ExpansionGoodRx announced a partnership with Novo Nordisk to offer an introductory cash price of $199 per month for Ozempic and Wegovy injection pens for GoodRx users.
Strategic CollaborationsGoodRx is actively engaged with HHS and the team building out the TrumpRx website, planning to integrate via API so that its pricing and platform are included as part of the repository of available cash prices.
Bears Say
Competitive PressuresSignificant competition in direct-to-consumer offerings like hair loss, sexual health, and weight loss could become a challenge for GDRX.
Market UncertaintyRecent market changes to pharmacy benefit manager contracts with plan sponsors add incremental uncertainty to GoodRx’s core business.
Retail Pharmacy ChallengesChallenges related to Rite Aid store closures, higher prices in the GoodRx app, benefit design changes in Medicare, and evolving PBM-to-pharmacy reimbursement landscape are expected to persist.
GoodRx Holdings News
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $2.66 and its highest was $5.81 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $913.07M.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Feb 26, 2026 which is in 98 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Nov 04, 2025. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.01.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.09.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 105,468,834 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went up 2.147%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
GoodRx Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.97 (78.14% Upside)
$4.97 (78.14% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 35.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $159.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 5.2%
Last 30 Days ▲ 5.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.55%
12-Months-Change
Fundamentals
Return on Equity
4.90%
Trailing 12-Months
Asset Growth
-2.17%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
GDRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced view with significant growth in Manufacturer Solutions and brand partnerships, offset by declines in prescription transaction revenue due to external factors. The company is optimistic about future growth opportunities and strategic initiatives.View all GDRX earnings summariesGDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
GDRX Stock 12 Month Forecast
Average Price Target
$4.97
▲(78.14% Upside)
Technical Analysis
Ownership Overview
11.65% Insiders
12.05% Mutual Funds
7.66% Other Institutional Investors
57.99% Public Companies and Individual Investors